ACE and diabetic kidney disease: Nevertheless, this minor effect is reversible, and as with angiotensin-converting-enzyme inhibitors (ACE-i) and angiotensin-receptor blockers (ARBs) [7,8], it provides renal protection on the long-run with an attenuation of the accelerated decline in GFR, characteristic of diabetic nephropathy.